US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on Nov. 18 for "Chimeric antigen receptor polypeptides and methods of using same" (California Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,344, issued on Nov. 18, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Chimeric antigen receptor polypeptides and methods of using same" was invented by Crystal Mackall (Stanford, Calif.), Michael Lin (Stanford, Calif.), Robbie Majzner (Palo Alto, Calif.), Hokyung Chung (San Diego) and Louai Labanieh (Stanford, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are polypeptides that include, from N-terminus to C-terminus, a chimeric antigen receptor (CAR), a protease, and a degron, where the polypeptide further includes a cleavage site for the protease disposed between the CAR and the ...